Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections (clinicaltrials.gov) - Mar 7, 2022 - P3 | N=284 | Recruiting | Sponsor: Valenta Pharm JSC
New P3 trial • Infectious Disease • Respiratory Diseases
|